According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), sentiment of U.S. newspaper articles covering lung cancer screening (LCS) from 2010 to 2022 was overall positive; however, certain key elements of LCS were infrequently mentioned

Line graph depicting number of U.S. newspaper articles covering LCS by year of publication, 2010-22. Key developments in lung cancer screening are annotated by year. Study period included only first 3 months of 2022, resulting in lower number of articles for that year. LCS = lung cancer screening. NLST = National Lung Screening Trial, USPSTF = U.S. Preventive Services Task Force, LDCT = low-dose CT, AAFP = American Academy of Family Physicians.


March 15, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), sentiment of U.S. newspaper articles covering lung cancer screening (LCS) from 2010 to 2022 was overall positive; however, certain key elements of LCS were infrequently mentioned. 

“The findings highlight areas for potential improvement of LCS media coverage; radiologists have an opportunity to take a more active role in this coverage,” concluded first author Brent P. Little, MD, of Mayo Clinic Florida in Jacksonville. 

Little et al. searched the ProQuest U.S. Newsstream database for news articles regarding LCS that were published from January 1, 2010—when National Lung Screening Trial results were published—to March 28, 2022. Their search included the following terms: lung cancer screening(s), lung screening(s), low dose screening(s), and LDCT. Results were reviewed to identify those articles mentioning LCS. After extracting article origination and characteristics, articles were then divided among nine independent readers to assess article sentiment regarding LCS, as well as additional content, using a standardized form. 

Ultimately, among 859 U.S. newspaper articles pertaining to LCS from 2010 to 2022, 76% had a positive sentiment regarding LCS. Enrollment criteria, smoking cessation programs, need for annual CT, shared decision making, and cost issues were mentioned in 4% to 52% of articles. Moreover, a radiologist was interviewed or mentioned in 9%. 

“Radiologists should recognize common deficiencies in newspaper coverage of LCS and take a more active role to optimize media coverage of this important imaging service,” the authors of this AJR accepted manuscript concluded

For more information: www.arrs.org 


Related Content

News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
Subscribe Now